Work

Phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of plaque psoriasis

Year: 2018

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2018.10.037

Authors: Kevin Robbins, Robert Bissonnette, Tomoko Maeda-Chubachi, Li Ye, Johnny Peppers, Kelly Gallagher, John E. Kraus

Institutions: GlaxoSmithKline (United States), Innovaderm (Canada), PRA Health Sciences

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: GlaxoSmithKline

Award: G6905528071

OpenAlex ID: W2898213950

FWCI: 3.84

Cites: 26

Cited by: 98

Related to: 10